Phase Ⅰ clinical tolerance trial of recombinant human Apo-2 ligand in patients with advanced cancer
ZHOU Sheng-yu
CHEN Shan-shan
LIU Peng
LUO Yang
XING Pu-yuan
HE Jing
SHI Yuan-kai
FENG Feng-yi
Machine-generated Keywords：
Publication Date：2007-01-01
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)
Pages：5( 71-75 )